Latest filing published 14 Nov 2023 for Tabula Rasa HealthCare, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian W. Adams (finance chief) discloses dealings in Tabula Rasa HealthCare, Inc. to SEC (Form 4). The record holds 78 filings, for trades running from 4 October 2016 to 3 November 2023.
Market trades split into 1 purchase (€64k) and 25 sales (€3.5M). Taken together, the sales exceed the purchases by €3.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 22 share grants and 26 option exercises.
Most recently, on 14 November 2023, the filings show a transaction in Tabula Rasa HealthCare, Inc. The last insider purchase was made public on 17 January 2018, 3,201 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations